Equitable Holdings’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.96M | Buy |
18,252
+1,238
| +7% | +$133K | 0.02% | 579 |
|
|
2025
Q1 | $1.72M | Buy |
17,014
+288
| +2% | +$29.1K | 0.02% | 557 |
|
|
2024
Q4 | $1.49M | Buy |
16,726
+274
| +2% | +$24.5K | 0.01% | 556 |
|
|
2024
Q3 | $1.38M | Buy |
16,452
+1,058
| +7% | +$88.7K | 0.01% | 590 |
|
|
2024
Q2 | $1.19M | Sell |
15,394
-1,350
| -8% | -$104K | 0.01% | 611 |
|
|
2024
Q1 | $1.15M | Sell |
16,744
-2,579
| -13% | -$177K | 0.01% | 586 |
|
|
2023
Q4 | $1.12M | Buy |
19,323
+352
| +2% | +$20.3K | 0.01% | 555 |
|
|
2023
Q3 | $1M | Sell |
18,971
-216
| -1% | -$11.4K | 0.01% | 539 |
|
|
2023
Q2 | $1.04M | Buy |
19,187
+369
| +2% | +$20K | 0.01% | 511 |
|
|
2023
Q1 | $941K | Buy |
18,818
+11
| +0.1% | +$550 | 0.02% | 482 |
|
|
2022
Q4 | $870K | Sell |
18,807
-253
| -1% | -$11.7K | 0.02% | 480 |
|
|
2022
Q3 | $738K | Buy |
19,060
+173
| +0.9% | +$6.7K | 0.01% | 466 |
|
|
2022
Q2 | $704K | Sell |
18,887
-1,544
| -8% | -$57.6K | 0.01% | 482 |
|
|
2022
Q1 | $905K | Buy |
20,431
+12
| +0.1% | +$532 | 0.01% | 429 |
|
|
2021
Q4 | $867K | Sell |
20,419
-3,961
| -16% | -$168K | 0.01% | 431 |
|
|
2021
Q3 | $1.06M | Sell |
24,380
-4,206
| -15% | -$183K | 0.02% | 367 |
|
|
2021
Q2 | $1.22M | Buy |
28,586
+6,426
| +29% | +$275K | 0.02% | 334 |
|
|
2021
Q1 | $856K | Sell |
22,160
-73
| -0.3% | -$2.82K | 0.02% | 382 |
|
|
2020
Q4 | $799K | Sell |
22,233
-737
| -3% | -$26.5K | 0.02% | 359 |
|
|
2020
Q3 | $878K | Sell |
22,970
-635
| -3% | -$24.3K | 0.02% | 326 |
|
|
2020
Q2 | $829K | Sell |
23,605
-763
| -3% | -$26.8K | 0.02% | 325 |
|
|
2020
Q1 | $795K | Buy |
24,368
+63
| +0.3% | +$2.06K | 0.03% | 299 |
|
|
2019
Q4 | $1.1M | Buy |
+24,305
| New | +$1.1M | 0.03% | 282 |
|